Today: 21 May 2026
Silver price dives nearly 22% as dollar rebounds — the next big catalysts traders are watching
30 January 2026
2 mins read

Silver price dives nearly 22% as dollar rebounds — the next big catalysts traders are watching

New York, Jan 30, 2026, 13:35 EST — Regular session

  • Spot silver down nearly 22% to about $90.66 an ounce after hitting a record $121.64 a day earlier.
  • Dollar firmer as investors reassess the U.S. interest-rate outlook, prompting profit-taking across precious metals.
  • Volatility spilled into silver-linked funds, with some leveraged products forced to rebalance intraday.

Spot silver fell 21.92% to $90.66 an ounce by 12:30 p.m. ET on Friday after Donald Trump said he would tap former Federal Reserve governor Kevin Warsh as the next chair. The metal touched $89.93 and was on track for its biggest daily drop on record, based on LSEG data, after scaling a record $121.64 on Thursday; it was still up more than 23% in January. Suki Cooper at Standard Chartered Bank said the dollar and expectations for “real yields” — inflation-adjusted bond returns — helped trigger profit-taking. Reuters

The reversal matters because the January run-up had become a momentum trade, fed by thin liquidity and fear of missing out as investors bet on sharp U.S. rate cuts. Tom Price at Panmure Liberum said the market saw Warsh as “rational” and not pushing “aggressively for rate cuts”. Ole Hansen of Saxo Bank said gold and silver were “ripe for a correction”, while independent analyst Ross Norman said “precious metals have discovered gravity”. Reuters

Warsh is set to take over when Jerome Powell’s term as Fed chair ends in May, and his confirmation process in Congress is expected to keep rate expectations in play. Markets see him as someone who would support lower rates but stop short of the more aggressive easing priced earlier in the week.

Just a day earlier, spot silver had eased 2.1% to $114.141 after reaching $121.64, and was up more than 60% for the month on supply deficits and momentum buying. Guy Wolf of Marex said the small silver market is vulnerable to speculative inflows that leave prices “totally detached” from physical demand. Reuters

Some of the rally has also leaned on the industrial case for silver — and on worries that China’s new licensing rules for exports could tighten supply if shipments slow. A Reuters Open Interest column said only 44 companies are approved to export the metal this year and next, and China shipped about 5,100 metric tons last year, the most since 2008. Given silver’s use in solar panels, the piece noted, traders are watching whether domestic demand starts taking priority over exports.

Leverage Shares plc said its 3x long silver product — a leveraged structure that targets three times the daily move — rebalanced intraday after iShares Silver Trust fell through a trigger in its index rules. It said SLV hit $87.89 at 11:11:25 EST, down 16.75% from $105.57, forcing an automatic rebalance.

For investors, the speed of the swing is the story. Silver can move like an industrial metal one hour, then trade like a crowded macro bet the next.

But the liquidation can feed on itself: falling prices can trigger margin calls, when brokers demand extra cash and positions get cut. That kind of mechanical selling can overwhelm physical demand signals, at least for a while.

Next up, traders are watching the U.S. jobs report for January, due on Feb. 6 at 8:30 a.m. ET from the U.S. Bureau of Labor Statistics, for any read-through to rate-cut pricing. Attention then shifts to liquidity around China’s nine-day Lunar New Year holiday, running Feb. 15-23, when trading desks and factories often slow.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion
Previous Story

Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus
Next Story

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Go toTop